10x Genomics Reports Second Quarter 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
10x Genomics (TXG) Misses Q2 EPS by 22c
August 8, 2022 4:53 PM EDT10x Genomics (NASDAQ: TXG) reported Q2 EPS of ($0.57), $0.22 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $114.6 million versus the consensus estimate of $117.64 million.
GUIDANCE:
10x Genomics sees FY2022 revenue of $500-520 million, versus the... More
